Optimization of a Digital Self-guided Psychological Intervention for Insomnia: A Randomized Factorial Experiment

March 10, 2025 updated by: Martin Kraepelien, Karolinska Institutet
In a previous pilot study, a digital self-guided intervention for insomnia showed preliminary positive effects on insomnia symptoms. In order to optimize the digital self-guided format, this study will evaluate the added value of three treatment features on treatment engagement and insomnia symptoms. The participants will be adults with insomnia. The trial will be a 2x2x2 randomized factorial experiment, where the following features/factors will be manipulated: an optimized graphical user interface (yes or no), an adaptive treatment strategy (yes or no), and daily prompts to use the intervention (yes or no). The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features. The main outcome will be the effect on treatment engagement.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

447

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Centre for Psychiatry Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. ≥ 18 years of age.
  2. ≥ 15 points on Insomnia Severity Index.
  3. Insomnia diagnosis, according to criteria in the Diagnostic and Statistical Manual of mental disorders-5 (somatic/psychiatric comorbidity is allowed).
  4. Good understanding of the Swedish language.
  5. No practical obstacles to participate in treatment and assessments.
  6. Daily access to computer/smart-phone/tablet with Internet access.
  7. Can receive phone calls and text messages during the study period.

Exclusion Criteria:

  1. Sleep diseases, such as narcolepsy or sleep apnea.
  2. Somatic or psychiatric illnesses that either are directly contraindicated for the treatment, require other treatment, or entail symptoms/a functional level making it too difficult to participate in the study.
  3. Alcohol/drug abuse, or medication with side effects on sleep (however, sleep medication is allowed).
  4. Working nights or night shifts.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Digital insomnia intervention
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (no).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + optimized user interface
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (no).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + adaptive treatment strategy
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (no).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + optimized user interface, adaptive treatment strategy
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (no).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (yes).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + optimized user interface, daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (yes).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + adaptive treatment strategy, daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (yes).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
Active Comparator: Digital insomnia intervention + optimized user interface, adaptive treatment strategy, daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (yes).
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Engagement with intervention method
Time Frame: Up to 12 months after treatment
Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better
Up to 12 months after treatment
Engagement with intervention method
Time Frame: Immediately after treatment (4 weeks after treatment start)
Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better
Immediately after treatment (4 weeks after treatment start)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Insomnia symptoms
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
Insomnia Severity Index (self-rated), score range 0-28, lower is better
Change from baseline (right before treatment start) up to 12 months after treatment
Change in Insomnia symptoms
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Insomnia Severity Index (self-rated), score range 0-28, lower is better
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Change in Depression symptoms
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better
Change from baseline (right before treatment start) up to 12 months after treatment
Change in Depression symptoms
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Change in Anxiety symptoms
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better
Change from baseline (right before treatment start) up to 12 months after treatment
Change in Anxiety symptoms
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Change in Life quality
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better
Change from baseline (right before treatment start) up to 12 months after treatment
Change in Life quality
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Change in Daily function
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better
Change from baseline (right before treatment start) up to 12 months after treatment
Change in Daily function
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
Treatment credibility
Time Frame: 2 weeks after treatment start (mid-treatment)
Credibility/Expectancy Questionnaire (self-rated), score range 0-50, higher is better
2 weeks after treatment start (mid-treatment)
Intervention/system usability
Time Frame: 2 weeks after treatment start (mid-treatment)
System Usability Scale (self-rated), score range 0-100, higher is better
2 weeks after treatment start (mid-treatment)
Treatment satisfaction
Time Frame: Immediately after treatment (4 weeks after treatment start)
Client Satisfaction Questionnaire-8 (self-rated), score range 8-32, higher is better
Immediately after treatment (4 weeks after treatment start)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinician time
Time Frame: Immediately after treatment (4 weeks after treatment start)
Time in minutes the clinician spends on the participant giving guidance through telephone calls and/or written guidance, in minutes, lower is better
Immediately after treatment (4 weeks after treatment start)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2023

Primary Completion (Actual)

December 15, 2024

Study Completion (Actual)

December 15, 2024

Study Registration Dates

First Submitted

March 27, 2023

First Submitted That Met QC Criteria

April 11, 2023

First Posted (Actual)

April 24, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 10, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

IPD available anonymized on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia

Clinical Trials on Digital self-guided psychological intervention for insomnia

Subscribe